Feasibility Study of a Diary for Allogenic Hematopoietic Stem Cell Transplantation Patients and Families
JACintHE
1 other identifier
interventional
20
1 country
1
Brief Summary
Allogenic hematopoietic stem cell transplantation is a specific time during hematological disease management for the patients, theirs relatives and the healthcare team. This heavy treatment is most of the time the last possible curative therapy and could cause many side effects such as infectious diseases and graft versus host reaction. The protective isolation is also a source of physical and psychological isolation. Published studies reported depressive syndrome, anxiety symptoms and post-traumatic stress disorders for patients and their families. Since 10 years ago, diaries are used in intensive care unit to limit these symptoms after a coma. In analogy, the diary for the patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long terms consequences. The investigators want to evaluate the psychological impact of a diary on the patients hospitalized for allogenic hematopoetic stem cell transplantation and on their relatives.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2019
CompletedFirst Submitted
Initial submission to the registry
November 14, 2019
CompletedFirst Posted
Study publicly available on registry
November 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2023
CompletedMarch 22, 2023
March 1, 2023
1.5 years
November 14, 2019
March 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Measure of diary impact on patient quality of life
the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.
at day 0
Measure of diary impact on patient quality of life
the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.
through the end of hospitalisation, an average of 3 weeks
Measure of diary impact on patient quality of life
the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.
at 30 days after transplantation
Measure of diary impact on patient quality of life
the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.
at day 100 after transplantation
Measure of diary impact on patient quality of life
the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.
6 months after transplantation
Measure of diary impact on patient quality of life
the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences.
a year after transplantation
Secondary Outcomes (12)
Measure of diary impact on health care team satisfaction
at day 0
Measure of diary impact on health care team satisfaction
through the end of hospitalisation, an average of 3 weeks
Measure of diary impact on health care team satisfaction
at 30 days after transplantation
Measure of diary impact on health care team satisfaction
at day 100 after transplantation
Measure of diary impact on health care team satisfaction
6 months after transplantation
- +7 more secondary outcomes
Study Arms (1)
Patients with diary
EXPERIMENTALEvaluation the psychological impact of a diary on the patients hospitalized for allogenic hematopoetic stem cell transplantation and on their relatives.
Interventions
Since 10 years ago, diaries are used in intensive care unit to limit these symptoms after a coma.In analogy, the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences. The psychological impact of a diary on patients hospitalized for allogenic hematopoetic stem cell transplantation and on their relatives will be evaluated.
Eligibility Criteria
You may qualify if:
- patient age \> 18 years
- patient hospitalized for an hematopoietic allogenic stem cell transplantation
- patient agreeing to participate
You may not qualify if:
- patient not hospitalized for an hematopoietic allogenic stem cell transplantation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens
Amiens, 80054, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Delphine Lebon, MD
CHU Amiens
- PRINCIPAL INVESTIGATOR
Marie Beaumont, MD
CHU Amiens
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2019
First Posted
November 21, 2019
Study Start
November 1, 2019
Primary Completion
May 1, 2021
Study Completion
March 21, 2023
Last Updated
March 22, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share